| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |